Transcriptional coregualtor NUPR1 maintains tamoxifen resistance in breast cancer cells

Lingling Wang(China Pharmaceutical University), Zhenyi Ma(Hangzhou Normal University)
Cell Death and Disease
February 4, 2021
Cited by 42


Related Papers